SlideShare a Scribd company logo
1 of 35
Download to read offline
BY SIMWANZA WEBSTER
8/28/2020 1
WEBSTER
 Is the commonest neonatal respiratory disease
 RDS due to 1. Deficiency of surfactant in the
infants lungs.
 2. immature lungs
8/28/2020 2
WEBSTER
 RDS – is an acute illness – usually of preterm
infants characterised by:
 a respiratory rate > 60/min
 dsypnoea (intercostal, subcostal recession and
sternal retraction)
 Predominantly diaphragmatic breathing
pattern
 Expiratory grunt
 Must be present within 4 – 6 hours of delivery
8/28/2020 3
WEBSTER
 Prematurity commonest predisposing factor to
RDS
 RDS common in infants < 30 weeks gestation
but can occur up to 34 weeks.
 Occurs invariably in infants < 28 weeks
gestation
 Can also occur in Term infants: e.g. Infants
born of a diabetic mother
8/28/2020 4
WEBSTER
 Perinatal asphyxia: Predisposes to RDS in
various ways:-
 Hypoxia: reduces surfactant synthesis
 Acidosis: also reduces surfactant synthesis
 Asphyxia damages the pulmonary vasculature,
allowing protein rich fluid to leak onto alveolar
surface where it inhibits surfactant activity
8/28/2020 5
WEBSTER
 The protein rich substance forms a hyaline
membrane on the surface of the alveolar
 Lungs become atelectic and non-compliant
 If child survives the first 2-3 days, there is an
increase in surfactant activity.
 Hyaline membrane subsequently absorbed
inflammatory cells e.g. macrophages
8/28/2020 6
WEBSTER
 However, sometimes organisation and fibrous
tissue formation occurs in the healing process,
especially in over ventilated children
 This causes chronic lung disease called
broncho-pulmonary dysplasia and eventual
death
8/28/2020 7
WEBSTER
 Maternal diabetes: is associated with an
increase in RDS.
 Cause is partly due to – early delivery (C/S)
 - and due to delay in
maturation of surfactant.
 Allowing delivery to be delayed to 38-40 weeks
gestation with good diabetic control almost
eliminates problem
8/28/2020 8
WEBSTER
 Caesarean section
 Caesarean section carried out before labour
starts in women beyond 32 weeks gestation
removes the B-adrenergic mediated surfactant
release
 Thus less surfactant is released
 Also interferes with removal of fluid from the
lungs during labour predisposing to transient
tachypnoea of the newborn
8/28/2020 9
WEBSTER
 Other predisposing factors include:
 Anti-partum haemorrhage
 Second twin
 Male: boys are more likely to die from the disease
and develop RDS. In boys maturation of RDS
delayed
 Shock
 Incidence higher amongst Caucasian infants than
black infants
 Assisted ventilation prolongs recovery from RDS
8/28/2020 10
WEBSTER
 Surfactant is an agent which reduces surface
tension in lungs
 Is produced by mature lung: thus surfactant
starts to appear in lungs at 20 weeks gestation
but is only sufficient after 34 weeks gestation
 The alveolus has two cell types: an alveolar cell
with thin protein containing cell wall –
pneumocyte type I and the thicker protein
containing cell wall - type II pneumocyte.
 Type II pneumocytes produce and release
surfactant into the alveolar lumen
8/28/2020 11
WEBSTER
 Surfactant is a protein containing dipalmitoyl
lecithin
 The dipalmitoyl lecithin is a phospoholipid
composed of lecithin and sphingomyelin
 Forms a film around the alveolar cells keeping
the alveolar open
 RDS occurs if lecithin:sphingomyelin ratio is
<2:1
8/28/2020 12
WEBSTER
 Intra-uterine growth retardation
 Maternal drug addiction
 Stressful pregnancy
8/28/2020 13
WEBSTER
 Avoid predisposing factors
 Administration of steroids antenatally to
mother
 Prophylactic administration of surfactant to
baby at resuscitation
8/28/2020 14
WEBSTER
 In order to prevent RDS in a baby being born
before 34 weeks of gestation steroid are given.
 The steroids include betamethasone and
glucortiocoids such as dexamethasone.
 The steroids have several effects:-
 They induce the enzyme for surfactant
synthesis and increase amount of surfactant
8/28/2020 15
WEBSTER
 They improve quality of surfactant produced
 They mature the non-surfactant producing
tissues of the lung
 They reduce the leakage of proteins out of
capillaries onto alveolar surface in asphyxia
 They promote postnatal closoure of patent
ductus arteriosus(PDA)
8/28/2020 16
WEBSTER
 A combination of steroids (Betamethasone)
and Thyroid releasing hormone (TRH) given to
the mother causes greater release of surfactant
as TRH crosses the placenta and stimulates
production of fetal thyroid hormones which
also promote surfactant maturation
8/28/2020 17
WEBSTER
 In newborn infant born before 34 weeks
gestation surfactant is given – within first few
minutes of birth through an intubation tube.
 More than one dose may be needed.
 Further doses are given at 1 hour and 24 hours
after birth
 There are different types of surfactant
preparation
8/28/2020 18
WEBSTER
 Asphyxiated babies must be immediately
intubated and oxygenated either via ambubag
or intermittent positive pressure ventilation.
 If no intubation tubes are available, patient
must still be ambubagged, holding up the chin
and neck appropriately.
 This eliminates acidosis, hypoxia and improves
ventilation, perfusion thereby reducing the
incidence of RDS
8/28/2020 19
WEBSTER
 This resuscitation causes adequate surfactant
release
 Thus resuscitation must be prompt and
vigorous
8/28/2020 20
WEBSTER
 Avoiding the above predisposing factors
 Administration of steroids antenatally
8/28/2020 21
WEBSTER
 During birth, fluid is squeezed out of infant’s
lungs by compression of chest as baby passes
through birth canal
 At first breath, baby makes large inspiratory
effort to expand lungs with air
 New born lung is stiff and will collapse if
surfactant is not present or is inadequate
8/28/2020 22
WEBSTER
 Due to inadequate surfactant, the alveoli
collapse and the lungs become very stiff. This
causes the following changes in pulmonary
physiology:
 Lung compliance falls to about 25% of normal
 There is increased work of breathing
 There is increase intra pulmonary shunting and
severe hypoxemia
 There is hypoventilation which causes a
respiratory acidosis
8/28/2020 23
WEBSTER
 Features which occur secondary to hypoxia
include
 High right sided heart pressure and high
pulmonary pressure causing a right to left
shunt through a Patent Ductus Arteriosus
(PDA)
 Vascular damage causing transudation no fluid
onto alveolar surface and into subcutaneous
tissue
8/28/2020 24
WEBSTER
 Hypotension
 Severe metabolic acidosis due to lactic acidosis
accumulation after anaerobic respiration
 Decreased perfusion and oxygenation of other
tissues predisposing to Necrotising
enterocolitis (NEC), renal failure
8/28/2020 25
WEBSTER
 Exudation of plasma into alveoli and airway
occurs further compromising surfactant
function
 This forms a hyaline membrane which lies the
respiratory bronchioles and alveolar ducts
8/28/2020 26
WEBSTER
 Earliest changes are interstitial oedema and
congestion of the alveolar walls leading to
desquamation of type II alveolar epithelial cells
 Alveolar ducts dilate but alveoli become
atelectatic because of surfactant deficiency
8/28/2020 27
WEBSTER
 RDS presents within 4 hours of birth with:-
 Sternal retraction, intercostal and subcostal
recession
 An expiratory grunt
 Tachypnoea above 60/min
 Signs and symptoms should be present before
four hours of age, should still be there at 4
hours of age and persist beyond 4 hours of age
8/28/2020 28
WEBSTER
 Child may be cyanosed
 Examination of the lungs reveals reduced air
entry and there may be a few crepitations.
 Baby is inactive. Tends to lie in frog position
 Blood pressure is 20-25% lower than normal for
gestation
 The patient has moderate generalised
subcutaneous oedema owing to capillary
leakiness
8/28/2020 29
WEBSTER
 Patient passes small amounts of urine
 Has an ileus
 May not pass meconium until 3rd – 4th day
8/28/2020 30
WEBSTER
 In uncomplicated RDS, surfactant begins to
reappear in lungs at about 36 – 48 hours of age.
 Illness initially gets worse over the first 24 – 36
hours and infant tires
 Subsequently his condition stabilizes and there
is a steady improvement form 60 – 72 hours of
age
8/28/2020 31
WEBSTER
 By end of week 1, patient has usually recovered
 However if assisted ventilation has been used,
recovery takes longer
8/28/2020 32
WEBSTER
 Investigations: Cxr shows ground glass
appearance
 Treatment:
 Ventilate: maintain adequate arterial
oxygenation or give additional Oxygen to
maintain partial pressure of oxygen at 9.2 to 12
kPa.
 Give surfactant if available
8/28/2020 33
WEBSTER
 If infant breathing spontaneously, give oxygen
by face mask or nasal prongs or head box
oxygen
 Indications for continuous positive airway
pressure:-
 Apnoea
 Hypercapnea
 Progressive hypoxia (IPPV must be used –
intermittent positive pressure ventilation)
8/28/2020 34
WEBSTER
 Minimal handling
 Stomach kept empty
 Intravenous fluid administration (10% dextrose
day 1 – 3 . Quarter strength darrows in 10%
dextrose day 4 onwards.)
 Keep warm – avoid hypothermia
8/28/2020 35
WEBSTER

More Related Content

Similar to Respiratory Distress Syndrome.pdf

neonatal physiology and transition period
neonatal physiology and transition periodneonatal physiology and transition period
neonatal physiology and transition periodanu_radha1209
 
Respiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptxRespiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptxEADavidKoli
 
neonatal physiology
neonatal physiologyneonatal physiology
neonatal physiologyShibinath VM
 
RESP 04 dev of respiratory sys medical anatomy .pdf
RESP 04 dev of respiratory sys medical anatomy .pdfRESP 04 dev of respiratory sys medical anatomy .pdf
RESP 04 dev of respiratory sys medical anatomy .pdfAHMED ASHOUR
 
CMC Pediatric X-Ray Mastery: 26th Case Series
CMC Pediatric X-Ray Mastery: 26th Case SeriesCMC Pediatric X-Ray Mastery: 26th Case Series
CMC Pediatric X-Ray Mastery: 26th Case SeriesSean M. Fox
 
Respiratory Distress(RDS)
Respiratory Distress(RDS)Respiratory Distress(RDS)
Respiratory Distress(RDS)Tek Khadka
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndromeTheShraddha
 
Surfactant Replacememt Therapy
Surfactant Replacememt Therapy Surfactant Replacememt Therapy
Surfactant Replacememt Therapy Mohammed Saeed
 
Respiratory distress syndrome [RDS]
Respiratory distress syndrome [RDS]Respiratory distress syndrome [RDS]
Respiratory distress syndrome [RDS]Alan Mizwari
 
Respiratory distress syndrome (RDS) in newborn
Respiratory distress syndrome (RDS) in newbornRespiratory distress syndrome (RDS) in newborn
Respiratory distress syndrome (RDS) in newbornPrabita Shrestha
 
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...IRAGUHA BANDORA Yves
 
normal pregnancy .ppt
normal pregnancy .pptnormal pregnancy .ppt
normal pregnancy .pptshariffson4
 
Meconium aspiration syndrome
Meconium aspiration syndromeMeconium aspiration syndrome
Meconium aspiration syndromeSheelendra Shakya
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxHanineHassan2
 

Similar to Respiratory Distress Syndrome.pdf (20)

neonatal physiology and transition period
neonatal physiology and transition periodneonatal physiology and transition period
neonatal physiology and transition period
 
Respiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptxRespiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptx
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
 
neonatal physiology
neonatal physiologyneonatal physiology
neonatal physiology
 
Physiology of transition
Physiology of transitionPhysiology of transition
Physiology of transition
 
RESP 04 dev of respiratory sys medical anatomy .pdf
RESP 04 dev of respiratory sys medical anatomy .pdfRESP 04 dev of respiratory sys medical anatomy .pdf
RESP 04 dev of respiratory sys medical anatomy .pdf
 
CMC Pediatric X-Ray Mastery: 26th Case Series
CMC Pediatric X-Ray Mastery: 26th Case SeriesCMC Pediatric X-Ray Mastery: 26th Case Series
CMC Pediatric X-Ray Mastery: 26th Case Series
 
Respiratory Distress(RDS)
Respiratory Distress(RDS)Respiratory Distress(RDS)
Respiratory Distress(RDS)
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
 
Surfactant Replacememt Therapy
Surfactant Replacememt Therapy Surfactant Replacememt Therapy
Surfactant Replacememt Therapy
 
Respiratory problems in neonate
Respiratory problems in neonateRespiratory problems in neonate
Respiratory problems in neonate
 
Respiratory distress syndrome [RDS]
Respiratory distress syndrome [RDS]Respiratory distress syndrome [RDS]
Respiratory distress syndrome [RDS]
 
Bronchopulmonary dysplasia
Bronchopulmonary dysplasiaBronchopulmonary dysplasia
Bronchopulmonary dysplasia
 
Respiratory distress syndrome (RDS) in newborn
Respiratory distress syndrome (RDS) in newbornRespiratory distress syndrome (RDS) in newborn
Respiratory distress syndrome (RDS) in newborn
 
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...
Prematurity & and its complication on different organs, Dr Iraguha Bandora Yv...
 
Neonatal Resuscitation
Neonatal ResuscitationNeonatal Resuscitation
Neonatal Resuscitation
 
normal pregnancy .ppt
normal pregnancy .pptnormal pregnancy .ppt
normal pregnancy .ppt
 
Meconium aspiration syndrome
Meconium aspiration syndromeMeconium aspiration syndrome
Meconium aspiration syndrome
 
RDS.pptx
RDS.pptxRDS.pptx
RDS.pptx
 
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptxNEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
NEONATAL RESPIRATORY CARE FROM A PHYSIO POV.pptx
 

More from Johnmvula3

SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjs
SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjsSINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjs
SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjsJohnmvula3
 
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjLecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjJohnmvula3
 
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsDISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsJohnmvula3
 
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxHUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxJohnmvula3
 
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjwJohnmvula3
 
Congenital Abnormalities.pptx
Congenital Abnormalities.pptxCongenital Abnormalities.pptx
Congenital Abnormalities.pptxJohnmvula3
 
Unit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfUnit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfJohnmvula3
 
Unite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxUnite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxJohnmvula3
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxJohnmvula3
 
OPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptOPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptJohnmvula3
 
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptSeizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptJohnmvula3
 
Intrauterine fetal death.ppt
Intrauterine fetal death.pptIntrauterine fetal death.ppt
Intrauterine fetal death.pptJohnmvula3
 
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfEPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfJohnmvula3
 
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfGlomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfJohnmvula3
 
Pancreatitis.pptx
Pancreatitis.pptxPancreatitis.pptx
Pancreatitis.pptxJohnmvula3
 
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfscrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfJohnmvula3
 
Major management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxMajor management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxJohnmvula3
 
6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptxJohnmvula3
 
Introduction to HSM 225.pptx
Introduction to HSM 225.pptxIntroduction to HSM 225.pptx
Introduction to HSM 225.pptxJohnmvula3
 
Cardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptCardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptJohnmvula3
 

More from Johnmvula3 (20)

SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjs
SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjsSINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjs
SINUSITIES.pptxgghshsjsjsjjsjsjsjsjsjsjjs
 
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjLecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
 
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsDISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
 
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxHUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
 
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
 
Congenital Abnormalities.pptx
Congenital Abnormalities.pptxCongenital Abnormalities.pptx
Congenital Abnormalities.pptx
 
Unit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdfUnit 5 Sickle cell-3.pdf
Unit 5 Sickle cell-3.pdf
 
Unite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxUnite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptx
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptx
 
OPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptOPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).ppt
 
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptSeizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
 
Intrauterine fetal death.ppt
Intrauterine fetal death.pptIntrauterine fetal death.ppt
Intrauterine fetal death.ppt
 
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfEPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
 
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfGlomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
 
Pancreatitis.pptx
Pancreatitis.pptxPancreatitis.pptx
Pancreatitis.pptx
 
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfscrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
 
Major management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxMajor management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptx
 
6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx
 
Introduction to HSM 225.pptx
Introduction to HSM 225.pptxIntroduction to HSM 225.pptx
Introduction to HSM 225.pptx
 
Cardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptCardiovascular drugs 1.ppt
Cardiovascular drugs 1.ppt
 

Recently uploaded

ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 

Recently uploaded (20)

ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 

Respiratory Distress Syndrome.pdf

  • 2.  Is the commonest neonatal respiratory disease  RDS due to 1. Deficiency of surfactant in the infants lungs.  2. immature lungs 8/28/2020 2 WEBSTER
  • 3.  RDS – is an acute illness – usually of preterm infants characterised by:  a respiratory rate > 60/min  dsypnoea (intercostal, subcostal recession and sternal retraction)  Predominantly diaphragmatic breathing pattern  Expiratory grunt  Must be present within 4 – 6 hours of delivery 8/28/2020 3 WEBSTER
  • 4.  Prematurity commonest predisposing factor to RDS  RDS common in infants < 30 weeks gestation but can occur up to 34 weeks.  Occurs invariably in infants < 28 weeks gestation  Can also occur in Term infants: e.g. Infants born of a diabetic mother 8/28/2020 4 WEBSTER
  • 5.  Perinatal asphyxia: Predisposes to RDS in various ways:-  Hypoxia: reduces surfactant synthesis  Acidosis: also reduces surfactant synthesis  Asphyxia damages the pulmonary vasculature, allowing protein rich fluid to leak onto alveolar surface where it inhibits surfactant activity 8/28/2020 5 WEBSTER
  • 6.  The protein rich substance forms a hyaline membrane on the surface of the alveolar  Lungs become atelectic and non-compliant  If child survives the first 2-3 days, there is an increase in surfactant activity.  Hyaline membrane subsequently absorbed inflammatory cells e.g. macrophages 8/28/2020 6 WEBSTER
  • 7.  However, sometimes organisation and fibrous tissue formation occurs in the healing process, especially in over ventilated children  This causes chronic lung disease called broncho-pulmonary dysplasia and eventual death 8/28/2020 7 WEBSTER
  • 8.  Maternal diabetes: is associated with an increase in RDS.  Cause is partly due to – early delivery (C/S)  - and due to delay in maturation of surfactant.  Allowing delivery to be delayed to 38-40 weeks gestation with good diabetic control almost eliminates problem 8/28/2020 8 WEBSTER
  • 9.  Caesarean section  Caesarean section carried out before labour starts in women beyond 32 weeks gestation removes the B-adrenergic mediated surfactant release  Thus less surfactant is released  Also interferes with removal of fluid from the lungs during labour predisposing to transient tachypnoea of the newborn 8/28/2020 9 WEBSTER
  • 10.  Other predisposing factors include:  Anti-partum haemorrhage  Second twin  Male: boys are more likely to die from the disease and develop RDS. In boys maturation of RDS delayed  Shock  Incidence higher amongst Caucasian infants than black infants  Assisted ventilation prolongs recovery from RDS 8/28/2020 10 WEBSTER
  • 11.  Surfactant is an agent which reduces surface tension in lungs  Is produced by mature lung: thus surfactant starts to appear in lungs at 20 weeks gestation but is only sufficient after 34 weeks gestation  The alveolus has two cell types: an alveolar cell with thin protein containing cell wall – pneumocyte type I and the thicker protein containing cell wall - type II pneumocyte.  Type II pneumocytes produce and release surfactant into the alveolar lumen 8/28/2020 11 WEBSTER
  • 12.  Surfactant is a protein containing dipalmitoyl lecithin  The dipalmitoyl lecithin is a phospoholipid composed of lecithin and sphingomyelin  Forms a film around the alveolar cells keeping the alveolar open  RDS occurs if lecithin:sphingomyelin ratio is <2:1 8/28/2020 12 WEBSTER
  • 13.  Intra-uterine growth retardation  Maternal drug addiction  Stressful pregnancy 8/28/2020 13 WEBSTER
  • 14.  Avoid predisposing factors  Administration of steroids antenatally to mother  Prophylactic administration of surfactant to baby at resuscitation 8/28/2020 14 WEBSTER
  • 15.  In order to prevent RDS in a baby being born before 34 weeks of gestation steroid are given.  The steroids include betamethasone and glucortiocoids such as dexamethasone.  The steroids have several effects:-  They induce the enzyme for surfactant synthesis and increase amount of surfactant 8/28/2020 15 WEBSTER
  • 16.  They improve quality of surfactant produced  They mature the non-surfactant producing tissues of the lung  They reduce the leakage of proteins out of capillaries onto alveolar surface in asphyxia  They promote postnatal closoure of patent ductus arteriosus(PDA) 8/28/2020 16 WEBSTER
  • 17.  A combination of steroids (Betamethasone) and Thyroid releasing hormone (TRH) given to the mother causes greater release of surfactant as TRH crosses the placenta and stimulates production of fetal thyroid hormones which also promote surfactant maturation 8/28/2020 17 WEBSTER
  • 18.  In newborn infant born before 34 weeks gestation surfactant is given – within first few minutes of birth through an intubation tube.  More than one dose may be needed.  Further doses are given at 1 hour and 24 hours after birth  There are different types of surfactant preparation 8/28/2020 18 WEBSTER
  • 19.  Asphyxiated babies must be immediately intubated and oxygenated either via ambubag or intermittent positive pressure ventilation.  If no intubation tubes are available, patient must still be ambubagged, holding up the chin and neck appropriately.  This eliminates acidosis, hypoxia and improves ventilation, perfusion thereby reducing the incidence of RDS 8/28/2020 19 WEBSTER
  • 20.  This resuscitation causes adequate surfactant release  Thus resuscitation must be prompt and vigorous 8/28/2020 20 WEBSTER
  • 21.  Avoiding the above predisposing factors  Administration of steroids antenatally 8/28/2020 21 WEBSTER
  • 22.  During birth, fluid is squeezed out of infant’s lungs by compression of chest as baby passes through birth canal  At first breath, baby makes large inspiratory effort to expand lungs with air  New born lung is stiff and will collapse if surfactant is not present or is inadequate 8/28/2020 22 WEBSTER
  • 23.  Due to inadequate surfactant, the alveoli collapse and the lungs become very stiff. This causes the following changes in pulmonary physiology:  Lung compliance falls to about 25% of normal  There is increased work of breathing  There is increase intra pulmonary shunting and severe hypoxemia  There is hypoventilation which causes a respiratory acidosis 8/28/2020 23 WEBSTER
  • 24.  Features which occur secondary to hypoxia include  High right sided heart pressure and high pulmonary pressure causing a right to left shunt through a Patent Ductus Arteriosus (PDA)  Vascular damage causing transudation no fluid onto alveolar surface and into subcutaneous tissue 8/28/2020 24 WEBSTER
  • 25.  Hypotension  Severe metabolic acidosis due to lactic acidosis accumulation after anaerobic respiration  Decreased perfusion and oxygenation of other tissues predisposing to Necrotising enterocolitis (NEC), renal failure 8/28/2020 25 WEBSTER
  • 26.  Exudation of plasma into alveoli and airway occurs further compromising surfactant function  This forms a hyaline membrane which lies the respiratory bronchioles and alveolar ducts 8/28/2020 26 WEBSTER
  • 27.  Earliest changes are interstitial oedema and congestion of the alveolar walls leading to desquamation of type II alveolar epithelial cells  Alveolar ducts dilate but alveoli become atelectatic because of surfactant deficiency 8/28/2020 27 WEBSTER
  • 28.  RDS presents within 4 hours of birth with:-  Sternal retraction, intercostal and subcostal recession  An expiratory grunt  Tachypnoea above 60/min  Signs and symptoms should be present before four hours of age, should still be there at 4 hours of age and persist beyond 4 hours of age 8/28/2020 28 WEBSTER
  • 29.  Child may be cyanosed  Examination of the lungs reveals reduced air entry and there may be a few crepitations.  Baby is inactive. Tends to lie in frog position  Blood pressure is 20-25% lower than normal for gestation  The patient has moderate generalised subcutaneous oedema owing to capillary leakiness 8/28/2020 29 WEBSTER
  • 30.  Patient passes small amounts of urine  Has an ileus  May not pass meconium until 3rd – 4th day 8/28/2020 30 WEBSTER
  • 31.  In uncomplicated RDS, surfactant begins to reappear in lungs at about 36 – 48 hours of age.  Illness initially gets worse over the first 24 – 36 hours and infant tires  Subsequently his condition stabilizes and there is a steady improvement form 60 – 72 hours of age 8/28/2020 31 WEBSTER
  • 32.  By end of week 1, patient has usually recovered  However if assisted ventilation has been used, recovery takes longer 8/28/2020 32 WEBSTER
  • 33.  Investigations: Cxr shows ground glass appearance  Treatment:  Ventilate: maintain adequate arterial oxygenation or give additional Oxygen to maintain partial pressure of oxygen at 9.2 to 12 kPa.  Give surfactant if available 8/28/2020 33 WEBSTER
  • 34.  If infant breathing spontaneously, give oxygen by face mask or nasal prongs or head box oxygen  Indications for continuous positive airway pressure:-  Apnoea  Hypercapnea  Progressive hypoxia (IPPV must be used – intermittent positive pressure ventilation) 8/28/2020 34 WEBSTER
  • 35.  Minimal handling  Stomach kept empty  Intravenous fluid administration (10% dextrose day 1 – 3 . Quarter strength darrows in 10% dextrose day 4 onwards.)  Keep warm – avoid hypothermia 8/28/2020 35 WEBSTER